Metformin in Non-Diabetics: Risks, Off-Label Uses, and Evidence Gaps
Standard Indication
Metformin is FDA-approved for type 2 diabetes (adjunct to diet/exercise). It lowers hepatic gluconeogenesis, increases insulin sensitivity, and modestly reduces intestinal glucose absorption.
Why Not for Non-Diabetics?
- Hypoglycemia risk: Rare with monotherapy (no insulin secretion ↑), but possible with malnutrition, alcohol, renal impairment, or combined with other glucose-lowering agents.
- GI adverse effects: Diarrhea, nausea, abdominal pain in 20–30% (dose-dependent).
- B12 deficiency: Long-term use ↓ intrinsic factor-mediated absorption.
- Lactic acidosis: Rare (3–10/100,000 patient-years) but fatal; contraindicated in eGFR <30, acute heart failure, hypoxia, sepsis.
Evidence-Based Off-Label Uses
| Condition | Evidence Strength | Notes |
|---|---|---|
| PCOS (ovulation induction) | Moderate | Adjunct to letrozole/clomiphene; improves insulin resistance |
| Antipsychotic-induced weight gain | Moderate | Attenuates gain; monitor B12 |
| Gestational Diabetes | Strong (RCTs) | Alternative to insulin in selected patients |
| Cancer prevention (breast, colon) | Observational only | RCTs ongoing (MA.32, METFORMIN) |
| Aging / Longevity | Preclinical / observational | TAME trial planned; not standard of care |
Clinical Bottom Line
Do not initiate metformin without a diagnosed indication. If prescribed off-label, ensure informed consent, baseline labs (eGFR, B12, LFTs), and monitoring plan.
Diabetes - Related Articles
- OneTouch Ultra 2 Meter Coding: A Guide for Accurate Readings
- Diabetic Foot Ulcers: Causes, Symptoms & Treatment
- Accurate Blood Glucose Testing: A Comprehensive Guide
- Vanadium for Feline Diabetes: A Potential Treatment Option
- Holiday Blood Sugar Management: Tips for Diabetic & Health-Conscious Diners
- Understanding Healthy Blood Sugar Levels: A Comprehensive Guide
- Preventing Gestational Diabetes: A Guide for Pregnant Women
